Chase Sun
3000263.380.90% ( +0.03 )
Chase Sun (300026)
Tianjin Chase Sun Pharmaceutical Co.,Ltd engages in the research, development, production, and sale of various pharmaceutical products in China. The company off...
- Open
- 3.34
- High
- 3.40
- Low
- 3.34
- Prev. Close
- 3.35
- Volume
- 215.81K
- Turnover
- 72.82M
- Avg Price
- 3.37
- Bid/Ask Ratio
- --
- Amplitude
- 1.79%
- 52wk High
- 4.48
- Volume Ratio
- 0.88
- Turnover Ratio
- 0.72%
Chase Sun Analyst Rating
View MoreForecast & Rating
Jul 1, 2026Price forecast
¥3.00-10.98%
Forecast & RatingBuy
1analysts
- Strong buy0.00%
- Buy100.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · 2 hours ago
CEC Capital advises Zhongkexinyang on 100-million-yuan private financing round
- Price Alert · 16 hours ago
Pre-market hot trades in US stocks: Planet Green fell 3.89% in pre-market; IREN rose 3.82% in pre-market
- London Stock Exchange · 2 days ago, 05:06 AM
REG - GSK PLC - Hansoh positive 2nd Phase III results for Riz-Rez
- benzinga_article · Jul 24 at 05:25 AM
Two Years to Build or Pay 200% — Which US Pharma Stocks Win?
- Zhitong · Oct 28, 2025 at 08:16 AM
Chase Sun Pharmaceuticals released its performance for the first three quarters, with a net profit attributable to the parent company of 80.7629 million yuan, a decrease of 52.03%
- Zhitong · Aug 27, 2025 at 03:09 AM
Chase Sun Pharmaceuticals released its performance for the first half of the year, with a net profit attributable to the parent company of 78.63 million yuan, a decrease of 46.95%
